---
figid: PMC7913382__jcm-10-00566-g001
figtitle: Illustration of the HER2 signalling pathway
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7913382
filename: jcm-10-00566-g001.jpg
figlink: pmc/articles/PMC7913382/figure/jcm-10-00566-f001/
number: F1
caption: Illustration of the HER2 signalling pathway. HER2 inhibitor (trastuzumab);
  HER2/EGFR inhibitors (lapatinib and afatinib); HER2/HER3 inhibitor (zenocutuzumab).
papertitle: The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic
  Cancer Therapies.
reftext: Andres Garcia-Sampedro, et al. J Clin Med. 2021 Feb;10(4):566.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9680341
figid_alias: PMC7913382__F1
figtype: Figure
redirect_from: /figures/PMC7913382__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7913382__jcm-10-00566-g001.html
  '@type': Dataset
  description: Illustration of the HER2 signalling pathway. HER2 inhibitor (trastuzumab);
    HER2/EGFR inhibitors (lapatinib and afatinib); HER2/HER3 inhibitor (zenocutuzumab).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - Akt
  - Erk7
  - rl
  - CycE
  - cyc
  - ERBB2
  - ERBB3
  - ERBB4
  - EGFR
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - Afatinib
  - Lapatinib
---
